A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 in Participants With Relapsed or Refractory T-cell Lymphomas in Japan
Condition:   Relapsed or Refractory T-cell Lymphomas Intervention:   Drug: BMS-986369 Sponsor:   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
Condition:   T Cell Lymphoma Interventions:   Drug: Mogamulizumab;   Drug: DA-EPOCH Protocol Sponsors:   Tarsheen Sethi;   Kyowa Kirin, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials